TABRECTA (capmatinib hydrochloride)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · NON-SMALL CELL LUNG CANCER WITH MESENCHYMAL-EPITHELIAL TRANSITION (MET) EXON 14 SKIPPING
Novartis Pharmaceuticals